Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SAMSCA: 236 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
236
Total FAERS Reports
53 (22.5%)
Deaths Reported
34
Hospitalizations
236
As Primary/Secondary Suspect
9
Life-Threatening
7
Disabilities

First Report: 2011 · Latest Report: 20170315

What Are the Most Common SAMSCA Side Effects?

#1 Most Reported
Incorrect drug administration duration
38 reports (16.1%)
#2 Most Reported
Off label use
33 reports (14.0%)
#3 Most Reported
Inappropriate schedule of drug administration
20 reports (8.5%)

All SAMSCA Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Incorrect drug administration duration 38 16.1% 0 0
Off label use 33 14.0% 2 5
Inappropriate schedule of drug administration 20 8.5% 0 2
Hypernatraemia 17 7.2% 7 1
Rapid correction of hyponatraemia 14 5.9% 2 4
Blood urea increased 13 5.5% 1 0
Death 13 5.5% 13 3
Wrong technique in drug usage process 13 5.5% 6 4
Blood sodium increased 11 4.7% 1 3
Thirst 11 4.7% 2 1
Blood sodium decreased 10 4.2% 3 4
No adverse event 10 4.2% 0 0
Wrong technique in product usage process 10 4.2% 0 0
Cardiac failure 9 3.8% 9 1
Blood creatinine increased 8 3.4% 3 1
Drug dose omission 8 3.4% 0 1
Incorrect drug administration rate 8 3.4% 4 6
Product use in unapproved indication 8 3.4% 0 0
Vomiting 8 3.4% 3 3
Dehydration 7 3.0% 1 3

Who Reports SAMSCA Side Effects? Age & Gender Data

Gender: 50.4% female, 49.6% male. Average age: 69.1 years. Most reports from: US. View detailed demographics →

Is SAMSCA Getting Safer? Reports by Year

YearReportsDeathsHosp.
2011 7 3 3
2012 10 6 2
2013 42 12 10
2014 42 10 9
2015 3 0 0
2016 37 0 3
2017 7 0 1

View full timeline →

What Is SAMSCA Used For?

IndicationReports
Hyponatraemia 60
Product used for unknown indication 43
Inappropriate antidiuretic hormone secretion 28
Oedema due to cardiac disease 23
Fluid retention 18
Blood osmolarity decreased 15
Cardiac failure 15
Oedema due to hepatic disease 15
Ascites 12
Blood sodium decreased 12

SAMSCA vs Alternatives: Which Is Safer?

SAMSCA vs SANDOSTATIN LAR SAMSCA vs SANDOZ FENTANYL SYSTEM SAMSCA vs SAPROPTERIN SAMSCA vs SAQUINAVIR SAMSCA vs SARECYCLINE SAMSCA vs SARGRAMOSTIM SAMSCA vs SARILUMAB SAMSCA vs SATRALIZUMAB SAMSCA vs SATRALIZUMAB-MWGE SAMSCA vs SAXAGLIPTIN

Official FDA Label for SAMSCA

Official prescribing information from the FDA-approved drug label.